Fact CheckerSign in

NCT07378423Recruiting

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Questionnaire on Congenital Cancer Signs Through Self-Assessment (QUOCCAS)

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

This clinical trial tests whether a patient- and caregiver-completed questionnaire (QUOCCAS) can accurately help identify children and adolescents with cancer who may have an underlying cancer predisposition syndrome (CPS). The study will also evaluate whether providing families with an educational brochure before their clinic visit improves their understanding of genetics and their satisfaction with care. The main questions it aims to answer are: * Does QUOCCAS identify children at risk for CPS as accurately as physician-based tools and compared to genetic testing? * Does the Pre-Visit Preparation (PVP) brochure improve caregiver knowledge about genetics? * Does the PVP brochure improve caregiver satisfaction with the care and information they receive? Participants will: * Complete the QUOCCAS questionnaire about family history, clinical features, and cancer signs * Provide a blood or saliva sample for genetic testing (whole-exome or whole-genome sequencing) * Randomly receive or not receive the educational Pre-Visit Preparation brochure before completing the questionnaire * Complete brief surveys on their knowledge and satisfaction

Status (registry)
Recruiting
Study type
Interventional
Enrollment
205 (estimated)
First submitted
18 Nov 2025
Start date
1 Apr 2026
Primary completion date
31 Dec 2028
Lead sponsor
Insel Gruppe AG, University Hospital Bern
NCT number
NCT07378423

What you commit to

  • Study type: Interventional
  • Planned participants: 205
  • From 1 Apr 2026 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Over 21 years of age

Who the study is looking for

  • The investigators will include newly diagnosed patients who received a cancer diagnosis included in the International Classification of Childhood Cancer version 3 (ICCC3) criteria, treated at participating hospitals

Age in the registry: - to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Inselspital, Universitäts Kinderklinik (University Children's Hospital) Bern
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.